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Problem Identification


In Maine (2014 )1 in 4 overdose deaths were due to
heroin/morphine (4)



Office based buprenorphine treatment is increasing as a safe opioid
dependence therapy option



EMMC Center for Family medicine has approximately 200 opioid
dependent patients on buprenorphine



Risks for patient relapse while on buprenorphine treatment has not
been previously discussed at this facility



We sought to understand patient perceived risks for relapse,
provider perceived risks for relapse, and chart determined risks for
relapse in order to provide future intervention strategies to prevent
relapse
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Public Health Cost


Societal costs in the United states of prescription opioid abuse in
2007 was 55.7 billion and continues to rise (1)



In 2010, the cost of drug abuse in Maine was approximately 1.4
billion dollars (2)



From 2011-2014 there has been a 34% increase in drug overdose
deaths in Maine (4)



From 2005-2014 the number of drug affected babies increased by
480% in Maine



Illicit drug use among 18-25 year olds was higher in Maine than
United States overall



There is not enough funding or treatment facilities to support the rise
in opioid abuse in this area (3)
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Community perspective
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Carol Peavy FNP, Provides buprenorphine treatment

Eric Brown MD, Certified in Family Medicine and Addiction Medicine
-

-

-

How do you see substance abuse impacting this community?
-

CP: Opioid use has skyrocketed since the late 90s. People in Maine are doing manual labor work and needed to
reduce pain. They were prescribed the medication by their doctors. The value for opioid pain medications went
up and people began selling and abusing the drugs.”

-

EB: “In Bangor in particular, substance abuse is extremely prevalent because of the large hospital providing
treatment for those using. There are currently not enough doctors in the area willing or trained to treat patients
with buprenorphine.”

What are the biggest risks for relapse while in treatment?
-

CP: “The number one risk from what I have seen is a partner who is using or not in treatment, next would be lost
insurance and third would be domestic abuse.”

-

EB: “I think our patients feel that not having family support, long distance to treatment and over strict requirements
for treatment increase their risk for relapse.”

What factors challenge their decision to stay in treatment?
-

CP: “Some people travel very far to come to their appointments and it is difficult to find transportation for all of
the required appointments. Also, Bangor is small and it is hard to get away from the drug atmosphere.”

-

EB: “Many of these patients are lacking insight into their long term goals and the health risks of relapsing.”

Intervention and Methodology
Goal


To gain a greater understanding relapse risk for patients undergoing office based
buprenorphine treatment program at EMMC Center for Family Medicine

Methodology


Completed retrospective chart analysis of at risk behaviors and 6 month relapse
occurrence



Surveyed EMMC CFM providers assessing physician perceived risk for relapse



Created patient centered discussion questions to explore barriers to treatment and
patient perceived risks

Intervention


Data from chart analysis will be compiled and analyzed for current research by Dr.
Jessica Bloom- Foster, Faculty at EMMC CFM



Lead group session with patients in treatment. Identified risks for relapse and barriers to
treatment to aid in future relapse prevention strategies
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Results
•

•
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Retrospective Chart Analysis
Completed for N=20

Mean Age

28.3

Analyzed: substance abuse
hx, mental health
diagnoses, and urine
toxicology screens.

Mean Age Use Began
Percent Female
Percent Pregnant

18.3
80%
69%

N=20

12%

Methodone
Oxycodone
Hydrocodone

56%

Total Relapse (N=6)
Pregnant Relapse
(N=1)

abusing drugs status.
(abusing=drug abuse)
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Heroin

30%
9%
Partner Status of
Relapsed Patients

Partner Status of
Patients in Recovery at 6 months

Months To Relapse
Number of Patients

28%
4%

Strongest correlation to
relapse existed with partner

•

Preferred Opiate or Opioid
at treatment Induction

2
1
0
1

2

3

4

Months to Relapse

5

6
Sober

None

Abusing

In treatment

Sober

None

Abusing

In Treatment

Retrospective chart analysis
discussion


Total relapse of 30% was consistent with previously collected data



There was a strong correlation between partner use and relapse



Pregnancy appeared to be a protective factor from relapsing



Pregnancy could be a motivational factor for change or current
program structure is more flexible with allowing treatment to
continue in pregnant patients who may have displayed problem
behaviors



After our discussion with patients and providers, transportation and
travel distance to treatment was identified as a potential risk factor
for relapse. Future studies could examine this factor in greater detail
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Results
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Provider Perceived Relapse
Risk (N=23)



Patient Centered Discussion



What are some of the biggest risk for relapse

Risk of relapse if partner is using opioids
0 4.35

13.04

8.7

73.91


1(Lowest Risk)

2

3

4

5(Highest risk)

Risk of relapse if missed 5 or more counseling
appointments
0%13%
52%

1(Lowest Risk)

2



35%

3

4

5 (Highest Risk)



Old friends



Long distance to clinic



Stress



Boredom



Judgement from providers

What are some strategies to help people start
treatment and remain in treatment


Support and encouragement from loved ones



Knowing when you need help



Change scenery



Peer support group

What is your quality of life since being in treatment


I have hope



Feel like I have a future



Proud at how far I have come

Effectiveness and Limitations


Effectiveness


Identified provider perspective on the most significant risks for relapse



Continued chart analysis to be included in future research



Discussed with patients their perceived risks for relapse in order to assist in
determining future intervention strategies






Determined that travel distance to clinic and the feeling of judgement at
appointments were two risks for relapse, according to patients

Determined that the greatest risks for relapse stated by physicians were
consistent with data obtained by chart analysis

Limitations


We were unable to get IRB approval, therefore we could not conduct a
formal group interview



Females were overrepresented in the retrospective data analysis



Small number of patients were present at our group discussions
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Recommendations


Obtain IRB approval to conduct a formal patient interview to collect
more information about patient perceived risk for relapse



Include travel distance to site as a factor when studying relapse risk
as many patients stated this was a barrier to receiving treatment
and staying in treatment



Continue to reinforce that providers should be non judgmental to
patients and provide an open environment where patients feel
comfortable



It would be most beneficial to the patients receiving treatment if
both partners would be treated. However, resources are limited and
this is a continued issue for EMMC CFM. It would be best to find other
locations where the partner could receive treatment if it is not at
EMMC CFM.
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Interview Consent form
Thank you for agreeing to be interviewed. This project is a requirement
for the Family Medicine clerkship. It will be stored on the Dana Library
ScholarWorks website. Your name will be attached to your interview
and you may be cited directly or indirectly in subsequent unpublished
or published work. The interviewer affirms that he/she has explained
the nature and purpose of this project. The interviewee affirms that
he/she has consented to this interview.
Yes
If not consenting as above: please add the interviewee names here for
the department of Family Medicine information only.
Name: Carol Peavy, FNP and Eric Brown, MD
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